MedPath

Sitagpina

Brand Name: Sitagpina

Generic Name: Sitagliptin (as phosphate monohydrate)

Active
Registration Number

DRP-8334

Dosage Form

Film-Coated Tablet

Issuance Date

May 31, 2024

Expiry Date

August 15, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Blood Glucose Lowering Drug
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Sitagliptin (as phosphate monohydrate)Active
Monograph: sitagliptin (as phosphate monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform